In Q4'25, CPNG's operating expenses totaled $2.54B USD, entirely driven by SG&A expenses at $2.54B USD, as R&D expenses remained at no data across all periods. This marks a slight quarterly decline from Q3'25's $2.56B USD total, reflecting stabilization in administrative costs. From Q1'23 to Q4'25, SG&A expenses exhibited strong growth, rising from $1.31B USD to $2.54B USD—a 94% increase—indicating expanding operational scale, with notable acceleration in 2024 (peaking at $2.18B USD in Q1'24) before moderating in 2025. R&D expenses showed no data throughout, suggesting minimal investment in this category; the stacked bar chart highlights SG&A as the dominant component, underscoring cost pressures from sales and administrative functions amid overall expense escalation.